knowledge -WSS

knowledge

author：comprehensive 2025-09-29 01:37:28 - browse：1

green electrocardiogram scan. -- health tech coverage from STAT — Adobe

As Bristol Myers Squibb works to build its treatment for a heart condition that can cause difficulty breathing into a blockbuster drug, it’s propped up an algorithm designed to help find more people who are affected.

The algorithm, which is part of software developed by Viz.ai, earlier this month received clearance from the Food and Drug Administration. The tool, called Viz HCM, looks at 12-lead electrocardiograms collected during routine care and flags suspected cases of hypertrophic cardiomyopathy, or HCM, for further evaluation. As part of a multi-year agreement between the companies, BMS — whose drug, Camzyos, is used to treat HCM — provided funding and scientific input for the development of the algorithm.

“BMS has a vested interest in finding more patients with HCM,” said Matthew Martinez, a cardiologist who leads Viz.ai’s HCM medical advisory board. “Why? Because they’re so philanthropic? No, they want to sell more drugs. They want to help more people by identifying more people.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Patients, doctors press FTC to beef up hospital merger scrutiny

WSS

The stability of $0 premiums in Medicare Advantage

Neurocrine congenital adrenal hyperplasia trial succeeds

Nobel honors Karikó and Weissman's enduring partnership

European officials brace for rough respiratory virus season

Assistant physicians can help address the primary care shortage

Nobel honors Karikó and Weissman's enduring partnership

focus

knowledge

explore

United colonoscopy coverage change 'may cost lives,' doctors say

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

Duchenne breakthrough therapy leaves behind pioneering families

People with substance use disorder deserve online privacy

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

With Roe v Wade overturned, abortion providers work to adapt

Trump demands the U.S. pay no more for drugs than other countries … again

Congress extends some pandemic preparedness programs

The high cost of giving birth even with insurance

Transgender sports debate: Physicians say bans are health issue

focus

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

Neurocrine congenital adrenal hyperplasia trial succeeds

WHO recommends second malaria vaccine

Health insurers' Q3 question: how much care are people getting?

PBMs drew scrutiny in House hearing — and so did pharma

Free Covid tests will again be offered to all U.S. households

hotspot

Wikipedia

focus

explore